Ardelyx, Inc.
(NASDAQ : ARDX)

( )
ARDX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.62%190.361.2%$564.46m
GILDGilead Sciences, Inc.
-0.52%70.550.9%$491.72m
BIIBBiogen Inc.
-1.73%313.551.3%$448.17m
CELGCelgene Corporation
-0.87%69.631.2%$426.13m
ILMNIllumina, Inc.
-0.95%308.233.5%$394.71m
REGNRegeneron Pharmaceuticals, Inc.
-1.41%337.292.6%$283.70m
VRTXVertex Pharmaceuticals Incorporated
-3.36%164.581.9%$265.75m
ALXNAlexion Pharmaceuticals, Inc.
-2.03%116.112.0%$195.76m
AAgilent Technologies, Inc.
-1.32%63.491.5%$175.37m
EXASExact Sciences Corporation
-1.38%68.4525.3%$145.96m
LGNDLigand Pharmaceuticals Incorporated
-0.42%147.8023.3%$142.63m
SRPTSarepta Therapeutics, Inc.
-4.09%111.9916.4%$134.89m
ECYTEndocyte, Inc.
-0.21%23.532.0%$121.26m
INCYIncyte Corporation
0.66%64.152.5%$116.78m
NKTRNektar Therapeutics
0.80%37.655.6%$109.74m

Company Profile

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicine for the treatment of renal diseases. It also focuses on the development of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.